Enid leads RG+A’s market access center of excellence, where she is responsible for working across the company’s engagements to advise RG+A’s pharmaceutical, biotechnology, and medical device clients on critical market access issues from early-stage through launch and post-launch market disruptions and loss of exclusivity. Throughout her career, Enid has designed and conducted research with a wide range of stakeholders, including payers, administrators, providers and consumers, driving strategic insights on pricing, contracting strategies, value positioning, and other key commercialization challenges. In her role, Enid serves as the Executive Director of RG+A‘s Health Payer Council (HPC), the only market research online community (MROC) exclusively for managed care medical and pharmacy directors.
Enid has been with RG+A since 2005, first as a qualitative moderator and then as a full-time staff member. Prior to joining RG+A, Enid spent 20 years practicing law, both in the criminal and civil arenas. She focused on litigation and other court room practice as well as writing appellate briefs and arguing them in both Federal and State Courts in New Jersey and New York.
She received a B.A. from Douglas College (Rutgers University) and a J.D. from Brooklyn Law School.